Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02487394 · ClinicalTrials.gov registry record
Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma
A clinical trial, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- 9
- Enrollment target
NCT02487394: Clinical Trial study, sponsored by The University of Texas Medical Branch, Galveston.
NCT02487394 is a clinical trial that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02487394 was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
The purpose of the study is to better understand proteomics of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, we propose is to use discovery proteomics and techniques to identify protein expression signatures. Subjects who complete Phase I are eligible, but not required, to enroll in Phase II. In Phase II, we propose to establish and validate the predictive value of protein signatures for treatment responses using inhaled corticosteroids.
Primary Outcome
Protein concentrations were below the limit of detectability and are not scientifically robust.
Interventions
- PROCEDURE Exhaled Breath Condensate (EBC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-06 |
Why NCT02487394 stopped before completion
NCT02487394 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Exhaled Breath Condensate (EBC) is the first listed.
NCT02487394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02487394 about?
NCT02487394 is a clinical study titled "Protein Biomarker Discovery and Validation in Chronic Obstructive Pulmonary Disease (COPD) And Asthma". The purpose of the study is to better understand proteomics of asthma and COPD, and response to therapy. There are two Phases to this study broken into two arms. In Phase I, we propose is to use discovery proteomics and techniques to identify protein expression signatures. Subjects who complete Phas...
What is the current status of trial NCT02487394?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2014-05. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02487394?
The interventions under investigation include: Exhaled Breath Condensate (EBC) (PROCEDURE).
Who is sponsoring clinical trial NCT02487394?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia